Holen Sie sich die Stockscreener-App
23.52
0.04%
0.01
Handel nachbörslich:
23.49
-0.025
-0.11%
Finanzdaten der Tourmaline Bio Inc-Aktie (TRML)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - |
Operating Expenses
|
7.34%
26.23
|
24.44 | 21.97 | 17.52 |
| Operating Income/Loss |
7.34%
-26.23
|
-24.44 | -21.97 | -17.52 |
| Income/Loss From Continuing Operations Before Tax |
13.84%
-22.97
|
-20.18 | -17.49 | -13.31 |
| Income/Loss From Continuing Operations After Tax |
13.84%
-22.97
|
-20.18 | -17.49 | -13.31 |
|
Net Income/Loss
|
13.84%
-22.97
|
-20.18 | -17.49 | -13.31 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - |
| Basic Average Shares |
0.29%
25.69
|
25.77 | 25.72 | 24.08 |
| Diluted Average Shares |
0.29%
25.69
|
25.77 | 25.72 | 24.08 |
| Basic Earnings Per Share |
14.10%
-0.89
|
-0.78 | -0.68 | -0.55 |
| Diluted Earnings Per Share |
14.10%
-0.89
|
-0.78 | -0.68 | -0.55 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - |
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):